Ipca Laboratories acquires Pisgah Labs Inc, USA
Ipca Laboratories have acquired the US-based Pisgah Labs Inc for $9.65 million. Pisgah is a contract manufacturer and developer of active pharmaceutical ingredients (APls) and […]
News
Alembic Pharma acquires US based West Caldwell
Alembic Pharmaceuticals has acquired a US based generic drug developer West Caldwell, New Jersey. With this acquisition Alembic will now have a total of 69 […]
Panacea Biotec ties up with Bionpharma
Panacea Biotec has entered into a joint collaboration with US generic drug maker Bionpharma Inc to develop, manufacture and sell seven complex generic drugs. The […]
IIL signs MoU with INTA and Littoral Biologics for vaccine
Indian Immunologicals Ltd IIL) has signed MoU with Instituto Nacional de Tecnologia Agropecuaria (INTA) and Littoral Biologics, Argentina for transfer of technology for Bovine Parasitic […]
Cadila Healthcare receives EIR for Changodar
Cadila Healthcare today has received Establishment Inspection Report (EIR) for its Changodar manufacturing plant located near Ahmedabad from the US health regulator after successful completion […]
DRL signs agreeement with CutisPharma
Dr. Reddys Laboratories has signed up Cutis Pharma of USA for active pharmaceutical ingredient (API) supply and joint development agreements. The company will engage in […]
Biocon receives Europe approval for Rosuvastatin calcium tablets
Biocon has received its first generic formulation approval in Europe to launch Rosuvastatin calcium tablets in several European countries. The product will be produced in […]
Biocon makes progress in oral insulin drug Tregopil
Biocon has made progress in phase-I clinical studies conducted in the US for insulin Tregopil and is looking at oral delivery of insulin. The company […]
Aurobindo Pharma to set up manufacturing facility in Saudi Arabia
Aurobindo Pharma is planning to set up a pharma plant in Phase one of the King Abdullah Economic City’s (KAEC) Industrial Valley in Saudi Arabia. […]
Indian government plans pharma technology upgradation fund for Rs. 5000 million
India is planning to set up a Rs 500-crore pharma technology upgradation fund which will facilitate cheaper loans to entities looking to upgrade their manufacturing […]